Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

Harmony Biosciences Holdings, Inc. Common Stock (HRMY)

Pharmaceutical Preparations

https://www.harmonybiosciences.com

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

630 W GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/19/2020

Market Cap

2,010,243,339

Shares Outstanding

58,570,000

Weighted SO

58,571,944

Total Employees

N/A

Upcoming Earnings

08/06/2024

Beta

0.7210

Last Div

0.0000

Range

18.611-39.265

Chg

0.1200

Avg Vol

374770

Mkt Cap

2010243339

Exch

NASDAQ

Country

US

Phone

484 539 9800

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

3.0639

EV Multiple

8.7950

P/FV

3.7303

Div Yield %

0.0000

P/E

17.4715

PEG

-0.5960

Payout

0.4806

Current Ratio

3.1269

Quick Ratio

3.0884

Cash Ratio

2.1646

DSO

46.2611

DIO

14.0117

Op Cycle

60.2728

DPO

56.3225

CCC

3.9503

Gross Margin

0.7760

Op Margin

0.2714

Pretax Margin

0.2515

Net Margin

0.1753

Eff Tax Rate

0.3031

ROA

0.1340

ROE

0.2297

ROCE

0.2502

NI/EBT

0.6969

EBT/EBIT

0.9265

EBIT/Rev

0.2714

Debt Ratio

0.2544

D/E

0.4055

LT Debt/Cap

0.2414

Total Debt/Cap

0.2885

Int Coverage

9.6439

CF/Debt

0.9776

Equity Multi

1.5938

Rec Turnover

7.8900

Pay Turnover

6.4805

Inv Turnover

26.0496

FA Turnover

201.1370

Asset Turnover

0.7644

OCF/Share

3.7591

FCF/Share

3.7460

Cash/Share

6.1073

OCF/Sales

0.3254

FCF/OCF

0.9965

CF Coverage

0.9776

ST Coverage

4.5445

CapEx Coverage

286.9933

Div&CapEx Cov

3.8126

P/BV

3.7303

P/B

3.7303

P/S

3.0639

P/E

17.4715

P/FCF

9.4476

P/OCF

9.4093

P/CF

9.4093

PEG

-0.5960

P/S

3.0639

EV Multiple

8.7950

P/FV

3.7303

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation